Pacer Advisors »

Arrivent Biopharma shares owned by Pacer Advisors

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Pacer Advisors from 13F filings

Historical chart of Pacer Advisors investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Pacer Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Pacer Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $14k 407 34.40

More positions owned by Pacer Advisors

NVIDIA Corp Common Stock - Domestic (NVDA)
Bristol-Myers Squibb Common Stock - Domestic (BMY)
Altria Group Common Stock - Domestic (MO)
Comcast Corp Common Stock - Domestic (CMCSA)
Apple Common Stock - Domestic (AAPL)
Booking Holdings Common Stock - Domestic (BKNG)
Verizon Communications Common Stock - Domestic (VZ)
Pfizer Common Stock - Domestic (PFE)
At&t Common Stock - Domestic (T)
Qualcomm Common Stock - Domestic (QCOM)
Gilead Sciences Common Stock - Domestic (GILD)
HCA Healthcare Common Stock - Domestic (HCA)
Lowe's Cos Common Stock - Domestic (LOW)
Uber Technologies Common Stock - Domestic (UBER)
Newmont Corp Common Stock - Domestic (NEM)

View all positions for Pacer Advisors

Top funds holding Arrivent Biopharma

Suvretta Capital Management
Infinitum Asset Management
Hillhouse Capital Advisors
BlackRock
OrbiMed Advisors
FMR
Octagon Capital Advisors
Vanguard Capital Management
Sofinnova Ventures
Vivo Capital
Novo A/S
General Catalyst Group Management
State Street Corporation
Logos Global Management
Geode Capital Management

View all funds holding Arrivent Biopharma